v
Search
Advanced Search

Publications > Journals > Exploratory Research and Hypothesis in Medicine > Article Full Text

  • OPEN ACCESS

Coronary Lesions in Patients with Atrial Fibrillation: A Retrospective Study

  • Yi-Wen Chen  and
  • Shu-Dong Xia* 
 Author information  Cite
Exploratory Research and Hypothesis in Medicine   2021;6(2):45-50

doi: 10.14218/ERHM.2020.00077

Abstract

Background and objectives

This study was performed to determine whether atrial fibrillation (AF) is related to the precise location of a coronary artery lesion.

Methods

A single-center retrospective study was conducted to compare data from clinical, laboratory, and instrumental examinations of 89 patients with AF (main group) who were admitted to the department between October 2015 and October 2019. One-hundred-and-sixty patients (comparison group) were selected according to balanced matching.

Results

There were no statistically significant differences in low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglycerides (TGs), troponin, or creatine kinase-myocardial band (CK-MB) between the two groups. However, the levels of homocysteine (17.0 ± 1.7 µmol/L vs. 13.7 ± 1.0 µmol/L, p = 0.001), uric acid (342.8 ± 16.7 µmol/L vs. 308.5 ± 15.1 µmol/L, p = 0.003) and creatinine (79.3 ± 4.7 µmol/L vs. 72.9 ± 3.1 µmol/L, p = 0.017) were higher in the AF group compared to the non-AF group. Moreover, the left atrium (LA) diameter (40.2 ± 1.4 mm vs. 33.5 ± 0.8 mm, p = 0.001) was larger in the AF group compared to the non-AF group. Patients with AF compared to those without AF had no significant differences in the degree or location of coronary artery lesions.

Conclusions

AF in patients was not associated with specific coronary artery lesions in the current study.

Keywords

Atrial fibrillation, Coronary heart disease, Coronary angiography, Homocysteine, Uric acid

Introduction

Atrial fibrillation (AF), the most commonly encountered cardiac arrhythmia in clinical practice, is the most important risk factor for myocardial infarction, ischaemic stroke, heart failure, and cardiovascular (CV) mortality.1 AF creates a very severe situation, which has caused a great burden on the social economy and medical resources.2 It has been identified that patients with advanced age, of the male sex, and with the presence of CV diseases are more susceptible to develop AF.3 Mechanisms leading to AF include remodelling of the atrial structure and ion channel function. Other factors such as hypertension, structural heart disease, possibly diabetes, and also AF itself induce a slow but progressive process of remodelling the atrial structure.2 Some studies have shown that AF is related to certain definite locations, the extent of coronary artery lesions, or types of coronary circulation. Yaroslavskaya et al. reported that AF in patients with ischaemic heart disease (IHD) is associated with right coronary artery lesions and right dominant coronary circulation.4 However, other studies have reported that the independent association of the absence of AF with the localization of significant coronary lesions indicates a mixed (coronary and non-coronary) AF origin in patients with coronary artery disease (CAD).5 Therefore, whether atrial coronary circulation plays an important role in the formation of AF is unknown. Further investigation is crucial. In the current study, a retrospective study was conducted to investigate the association between AF and coronary artery lesions.

Methods

Patient selection

This single-center retrospective study was performed to investigate the association between AF and coronary artery lesions. The ethics committee of the Fourth Affiliated Hospital of Zhejiang University School of Medicine approved the use of clinical data, the informed consent was waived due to the retrospective nature of the analysis, and the protocols were confirmed to follow the ethical guidelines of the latest version of the Declaration of Helsinki.

The medical records were reviewed of 195 patients hospitalized in the Fourth Affiliated Hospital of Zhejiang University School of Medicine, between October 2015 and October 2019, who underwent a coronary angiogram procedure due to recurrent chest pain/chest tightness, a long history of angina, or other symptoms such as dyspnea. Exclusion criteria included patients with acute coronary syndrome (ACS), advanced heart failure, valvular heart disease, cardiomyopathy, chronic lung disease, severe liver and renal insufficiency, chronic severe anaemia, chronic hypertension (HT) with poorly controlled blood pressure, and patients with thyroid disease. All patients underwent an electrocardiogram (ECG) and a 24-hour Holter ECG on admission. AF was first divided into two categories: paroxysmal AF (sudden onset) or chronic AF (persistent and permanent). One-hundred-and-six patients (comparison group) were selected according to propensity score matching with balancing by age, sex, and body mass index (BMI) from a group that was mechanically sampled (every 20 patients) from a chronological cohort of non-AF patients. Finally, 89 patients with AF (main group) and 106 patients (comparison group) were elected for the study. Demographic data and laboratory results, including total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglycerides (TGs), homocysteine (Hcy), uric acid (UA), creatinine levels, troponin, and creatine kinase-myocardial band (CK-MB) were recorded.

Echocardiographic examination

Motion (M)-mode echocardiography and quantitative analysis were conducted using parasternal long-axis images. The left atrium (LA) diameter, left ventricular end-systolic diameter (LVESD) and left ventricular end-diastolic diameter (LVEDD), interventricular septum (IVS) thickness, and left ventricular ejection fraction (LVEF) were calculated according to the biplane modified Simpson’s method.6

Holter monitoring

All participants were monitored using the 24-hour Holter ECG system on admission. AF was defined as absolutely irregular RR intervals with fibrillatory waves and no defined P waves on surface ECG.6

Coronary angiography

All patients underwent coronary angiography in the catheter laboratory. Coronary angiograms were saved in digital format. The main coronary vessels for analysis included the left main branch (LM) as well as the proximal, middle, and distal sections of the left anterior branch (LAD), the left circumflex branch (LCX), and the right coronary artery (RCA). A total of 50% vascular stenosis was defined as a critical lesion of the coronary arteries.

Statistical analysis

Continuous variables were expressed as mean ± standard deviation. Categorical variables were expressed as absolute numbers and percentages. The differences in continuous variables were assessed using the independent sample Student’s t-test or one-way analysis of variance (ANOVA) and the chi-square test was used to test for differences among the subtypes of AF. A p-value < 0.05 was considered statistically significant. Statistical analyses were performed using SPSS software (version 25.0; IBM Corp.; Armonk, NY, USA).

Results

Patient characteristics

The baseline characteristics of the AF and non-AF groups are shown in Table 1. The two groups did not differ regarding sex, mean age, body mass index(BMI), smoking rates, drinking rates, or HT. However, patients with AF have a higher incidence of diabetes. Paroxysmal AF was the most frequent type observed (35%, 28/79) and the prevalence of permanent AF was marginally lower (30%, 24/79). The laboratory, electrocardiographic, and echocardiographic results of the study patients are shown in Table 2. Troponin and CK-MB were within the normal range, which further excluded ACS. There were no statistically significant differences in TC, LDL-C and HDL-C, TGs, and IVS between the two groups, while the levels of Hcy, UA, and creatinine in the AF group were higher than those in the non-AF group. The average heart rate and LVEF in the AF group were also higher compared to the non-AF group. Moreover, the LVEDD, LVESD, and LA diameter were larger in the AF group. However, there was no significant difference in IVS thickness between the two groups.

Table 1

Baseline demographic and clinical features of the study population

VariablesAF patients (n = 89)Non-AF patients (n = 106)p-value
Age, years68.5 ± 1.666.5 ± 1.30.054
Sex, M/F58520.361
BMI, kg/m225 ± 0.724 ± 0.90.202
Smoking rate, %25260.787
Drinking rate, %19160.574
DM, %17290.042
HT, %66620.559
Table 2

Laboratory, electrocardiographic, and echocardiographic results of the study population

VariablesAF patients (n = 89)Non-AF patients (n = 106)p-value
TC, mmol/L3.7 ± 0.23.7 ± 0.20.882
LDL-C, mmol/L1.9 ± 0.21.8 ± 0.10.193
HDL-C, mmol/L1.1 ± 0.11.1 ± 0.10.805
TGs, mmol/L1.4 ± 0.21.5 ± 0.20.339
Hcy, µmol/L17.0 ± 1.713.7 ± 1.00.001
UA, µmol/L342.8 ± 16.7308.5 ± 15.10.003
Creatinine, µmol/L79.3 ± 4.772.9 ± 3.10.017
Average heart rate, bpm73.6 ± 3.067.3 ± 1.40.001
LVEDD, mm48.4 ± 1.046.7 ± 0.80.010
LVESD, mm31.5 ± 1.429.6 ± 0.70.010
IVS thickness, mm9.6 ± 0.39.4 ± 0.30.273
LA diameter, mm40.2 ± 1.433.5 ± 0.80.001
LVEF, %63.6 ± 1.766.6 ± 1.20.005

Coronary angiography

The analysis of coronary angiography data is shown in Table 3. Patients with AF compared with those without AF had no significant differences in the degree or location of coronary artery lesions.

Table 3

Coronary angiography data of the study population

VariablesAF patients (n = 89)Non-AF patients (n = 106)p-value
LM, %9.43.40.092
LAD, %
  Proximal34.853.80.080
  Middle31.531.10.961
  Distal9.06.60.534
LCX, %
  Proximal18.015.10.588
  Middle15.723.60.172
  Distal11.218.90.141
RCA, %
  Proximal14.622.60.154
  Middle19.130.20.075
  Distal12.415.10.582

Atrial fibrillation population

The mean HAS-BLED score (that considers hypertension, abnormal renal and liver function; stroke, bleeding, labile INR, elderly, drugs or alcohol) was 1.45 in AF patients while the mean CHA2DS2-VASc score (that considers congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, stroke or transient ischemic attack, vascular disease, age 65–74 years, sex condition) was 2.61. Results of the three groups of AF patients are shown in Figure 1. There was statistical significance in eight indicators including age, HT, heart rate, CHA2DS2-VASc score, HAS-BLED score, the middle sections of LCX, and the distal sections of RCA. Permanent AF patients were the oldest, had the highest prevalence of HT, had the highest CHA2DS2-VASc and HAS-BLED scores, and had more lesions in the middle sections of the LCX and the distal sections of the RCA.

Comparison between paroxysmal, persistent, and permanent AF.
Fig. 1  Comparison between paroxysmal, persistent, and permanent AF.

AF, atrial fibrillation; CHA2DS2-VASc score: congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, stroke or transient ischemic attack, vascular disease, age 65-74 years, sex condition; HAS-BLED score: hypertension, abnormal renal and liver function; stroke, bleeding, labile INR, elderly, drugs or alcohol; HT, hypertension; LCX, the left circumflex branch; RCA, the right coronary artery.

Discussion

In this retrospective analysis, the levels of Hcy, creatinine, and UA were significantly associated with AF. The above indicators were higher in patients with AF compared with those without. Moreover, patients with AF had faster average heart rates, larger left ventricular and left atrial volumes, and reduced ejection fractions.

Hcy, a sulphur-containing amino acid, is an intermediate by-product during the metabolism of dietary methionine7 and is associated with a number of cardiovascular events, including stroke, CAD, venous thromboembolism, and HT.8 Many studies have reported that plasma Hcy levels are elevated in AF patients and that they are affected by age and gender.7 Yao et al. further reported that plasma Hcy levels may increase the early recurrence of atrial tachyarrhythmia after catheter ablation in persistent AF patients.9 AF is the result of electrical and structural atrial remodelling.10,11 Current studies have found that hyperhomocysteinaemia may cause structural atrial remodelling in AF patients by activating the extracellular signal regulated kinase–matrix metalloproteinase-9 signalling axis,12 resulting in oxidative stress and inducing an inflammatory response.13,14 It has also been reported that hyperhomocysteinaemia can inhibit potassium channels in atrial myocytes and cause atrial electrical remodelling.15 It is now highly recognized that diet supplementation with folic acid and vitamin B can lower Hcy levels.7 However, research on whether vitamin B supplementation can prevent cardiovascular disease in patients with AF is not uniform and needs further confirmation.

UA, produced in the liver, muscles, and intestines, is an end-product of purine metabolism in humans.16 A number of previous studies have shown a positive association between serum uric acid (SUA) and the prevalence of AF17 in both hypertensive18 and chronic systolic heart failure patients.19 It has been reported that SUA is clearly associated with inflammation and oxidative stress in certain pathological conditions.17 As the final product of purine metabolism, SUA aggravates cellular damage through oxidative stress.20,21 Moreover, SUA promotes inflammation by stimulating the release of pro-inflammatory cytokines,22–24 resulting in atrial structural remodelling. Importantly, both electrical and structural remodelling contribute to the occurrence and development of AF.25

Several previous studies found that elevated creatinine levels may increase adverse events in patients with AF, including CV mortality and major bleeding in patients receiving oral anticoagulants.26 Creatinine levels are also considered an auxiliary reference standard to assist in the CHA2DS2-VASc score, which is used to assess the risk of stroke in AF patients. Research concerning the impact of AF per se on creatinine levels is not sufficient. AF affects microvascular flow in different organs,27 especially in the left ventricle, brain, and kidneys. However, patients with AF often have other coexisting diseases, such as diabetes mellitus and arterial hypertension. These factors as well as ageing may affect creatinine levels.28 Thus, whether the elevation of creatinine levels is solely an epiphenomenon induced by the presence of vascular risk factors or is directly associated with these many complications is unclear.

AF contributes to the progression of CHF,29 and its main causes are hemodynamic disturbances caused by the absence of full atrial contractions, mismatch of atrioventricular interaction, and uneven ventricular filling.4 In addition, remodelling of the atrial myocardium plays a special role that may precede the development of AF in many patients with accompanying myocyte hypertrophy, fibrosis, or impairment of the electrophysiological properties of the myocardium.2 The intergroup differences that were detected (heart rate, LA, ventricle size, etc.) were due to the presence or absence of AF, which was consistent with the existing theory, and it was also found that the permanent AF patients had the highest CHA2DS2-VASc and HAS-BLED scores, and had more lesions in the middle section of the LCX and the distal section of the RCA. Statistically significant differences were not found in LVEFs between the two groups in the current study, which may be due to the fact that some advanced heart failure were excluded, and patients who were included in our cohort had not reached cardiac insufficiency yet. In addition, this study also investigated the relationship between AF and some definitive locations or the extent of the coronary artery lesions. However, a clear correlation was not found between the incidence of AF and coronary artery lesions. Based on this negative result, it was considered that patients with AF completed stress tests and computed tomography scans less frequently because of the rapid rhythm. Furthermore, coronary angioplasty was also less common compared to those with sinus rhythm. This raises the possibility that it may be difficult to discover patients with AF for invasive procedures.

The current study has several limitations. Firstly, the results were based on a small population and were obtained from a retrospective single-centre study. Secondly, some excluded patients may lead to a selection bias. Thirdly, fractional flow reserve measurements were not performed to accurately assess the significance of coronary stenosis. Therefore, only cases of stenosis with a reduction of 50% were defined as significant. Fourthly, medications (lipid-lowering, antidiabetic, antihypertensive or other drugs) were not considered within the study groups. Fifthly, retrospective databases have some limitations such as potential selection bias, which should be taken into consideration. Lastly, newly diagnosed AF was not considered.5

Future directions

Given that the findings were based on a small population and were obtained from a retrospective single-centre study, a multi-centre prospective study should be conducted to verify these results.5 As mentioned above, coronary angioplasty was less common in patients with AF compared to those with sinus rhythm. This raises the possibility that it may be difficult to discover patients with AF for invasive procedures. Therefore, there may be a need for a more efficacious non-invasive diagnostic approach for patients with AF and suspected chronic coronary syndrome (CCS). Use accurate non-invasive method to assess the patient’s coronary artery, and then compare whether there are statistical differences in coronary artery between patients with AF and non-AF.

Conclusions

Hcy, creatinine and UA levels were associated with AF, and they also were associated with a faster average heart rate, larger left ventricular and left atrial volumes, and a smaller ejection fraction. This study did not find a specific correlation between the occurrence of AF and specific coronary artery lesions. However, during the analysis of the three subtypes of AF, it was revealed that in the cases of permanent AF, thrombosis and bleeding events were more likely to occur, and there were more lesions in the middle section of the LCX and the distal section of the RCA.

Abbreviations

AF: 

atrial fibrillation

BMI: 

body mass index

CAD: 

coronary artery disease

CCS: 

chronic coronary syndrome

CV: 

cardiovascular

DM: 

diabetes mellitus

ECG: 

electrocardiogram

Hcy: 

homocysteine

HDL-C: 

high density lipoprotein cholesterol

HL: 

hyperlipidemia

HT: 

hypertension

IHD: 

ischemic heart disease

IVS: 

interventricular septum

LA: 

left atrium

LAD: 

left anterior branch

LCX: 

the left circumflex branch

LDL-C: 

low density lipoprotein cholesterol

LM: 

left main branch

LVEDD: 

left ventricular end-diastolic diameter

LVEF: 

left ventricular ejection fraction

LVESD: 

left ventricular end-systolic diameter

RCA: 

the right coronary artery

TC: 

total cholesterol

TGs: 

triglycerides

TTE: 

chest echocardiogram

UA: 

uric acid

Declarations

Acknowledgement

None.

Data sharing statement

The data that support the findings of this study are available from the corresponding author, SDX, upon reasonable request.

Funding

This work was supported by the General Research Project of Zhejiang Provincial Department of Education.

Conflict of interest

The authors have no conflict of interest related to this publication.

Authors’ contributions

Study design (SDX), performance of experiments (YWC), analysis and interpretation of data (YWC), manuscript writing (YWC), critical revision (SDX).

References

  1. Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med 2002;113(5):359-364 View Article
  2. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016;37(38):2893-2962 View Article
  3. Vermond RA, Geelhoed B, Verweij N, Tieleman RG, Van der Harst P, Hillege HL, et al. Incidence of atrial fibrillation and relationship With cardiovascular events, heart failure, and mortality: a community-based study from the Netherlands. J Am Coll Cardiol 2015;66(9):1000-1007 View Article
  4. Yaroslavskaya EI, Kuznetsov VA, Gorbatenko EA, Marinskikh LV. Association of atrial fibrillation with coronary lesion in ischemic heart disease patients (in Russian). Kardiologiia 2019;59(9):5-12 View Article
  5. Tomaszuk-Kazberuk A, Koziński M, Kuźma Ł, Bujno E, Łopatowska P, Rogalska E, et al. Atrial fibrillation is more frequently associated with nonobstructive coronary lesions: the Bialystok Coronary Project. Pol Arch Intern Med 2020;130(12):1029-1036 View Article
  6. Nabi Aslan A, Bastug S, Ahmet Kasapkara H, Can Guney M, Sivri S, Bozkurt E. Coronary artery dominance may predict future risk of atrial fibrillation. Acta Cardiol Sin 2018;34(4):344-351 View Article
  7. Yao Y, Gao LJ, Zhou Y, Zhao JH, Lv Q, Dong JZ, et al. Effect of advanced age on plasma homocysteine levels and its association with ischemic stroke in non-valvular atrial fibrillation. J Geriatr Cardiol 2017;14(12):743-749 View Article
  8. Han L, Wu Q, Wang C, Hao Y, Zhao J, Zhang L, et al. Homocysteine, ischemic stroke, and coronary heart disease in hypertensive patients: a population-based, prospective cohort study. Stroke 2015;46(7):1777-1786 View Article
  9. Yao Y, Yao W, Bai R, Lu ZH, Tang RB, Long DY, et al. Plasma homocysteine levels predict early recurrence after catheter ablation of persistent atrial fibrillation. Europace 2017;19(1):66-71 View Article
  10. Dzeshka MS, Lip GY, Snezhitskiy V, Shantsila E. Cardiac fibrosis in patients with atrial fibrillation: mechanisms and clinical implications. J Am Coll Cardiol 2015;66(8):943-959 View Article
  11. Nattel S, Burstein B, Dobrev D. Atrial remodeling and atrial fibrillation: mechanisms and implications. Circ Arrhythm Electrophysiol 2008;1(1):62-73 View Article
  12. Moshal KS, Singh M, Sen U, Rosenberger DS, Henderson B, Tyagi N, et al. Homocysteine-mediated activation and mitochondrial translocation of calpain regulates MMP-9 in MVEC. Am J Physiol Heart Circ Physiol 2006;291(6):H2825-H2835 View Article
  13. Steed MM, Tyagi SC. Mechanisms of cardiovascular remodeling in hyperhomocysteinemia. Antioxid Redox Signal 2011;15(7):1927-1943 View Article
  14. Lentz SR. Mechanisms of homocysteine-induced atherothrombosis. J Thromb Haemost 2005;3(8):1646-1654 View Article
  15. Cai BZ, Gong DM, Liu Y, Pan ZW, Xu CQ, Bai YL, et al. Homocysteine inhibits potassium channels in human atrial myocytes. Clin Exp Pharmacol Physiol 2007;34(9):851-855 View Article
  16. Ono K. How is uric acid related to atrial fibrillation?. Circ J 2019;83(4):705-706 View Article
  17. Chen Y, Xia Y, Han X, Yang Y, Yin X, Qiu J, et al. Association between serum uric acid and atrial fibrillation: a cross-sectional community-based study in China. BMJ open 2017;7(12):e019037 View Article
  18. Liu T, Zhang X, Korantzopoulos P, Wang S, Li G. Uric acid levels and atrial fibrillation in hypertensive patients. Intern Med 2011;50(8):799-803 View Article
  19. Liu Y, Liu H, Dong L, Chen J, Guo J. Prevalence of atrial fibrillation in hospitalized patients over 40 years old: ten-year data from the People’s Hospital of Peking University. Acta Cardiol 2010;65(2):221-224 View Article
  20. Korantzopoulos P, Kolettis TM, Galaris D, Goudevenos JA. The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol 2007;115(2):135-143 View Article
  21. Dudley SC, Hoch NE, McCann LA, Honeycutt C, Diamandopoulos L, Fukai T, et al. Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases. Circulation 2005;112(9):1266-1273 View Article
  22. Kang DH, Han L, Ouyang X, Kahn AM, Kanellis J, Li P, et al. Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter. Am J Nephrol 2005;25(5):425-433 View Article
  23. Baldwin W, McRae S, Marek G, Wymer D, Pannu V, Baylis C, et al. Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome. Diabetes 2011;60(4):1258-1269 View Article
  24. Kanellis J, Watanabe S, Li JH, Kang DH, Li P, Nakagawa T, et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 2003;41(6):1287-1293 View Article
  25. Korantzopoulos P, Letsas KP, Liu T. Xanthine oxidase and uric acid in atrial fibrillation. Front Physiol 2012;3:150 View Article
  26. Goette A. Atrial fibrillation and stroke risk factors induce decline in creatinine clearance: Is there a specific “fibrillatory kidney disease”?. Int J Cardiol 2018;253:82-83 View Article
  27. Goette A, Kalman JM, Aguinaga L, Akar J, Cabrera JA, Chen SA, et al. EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. Europace 2016;18(10):1455-1490 View Article
  28. Rossi GP, Seccia TM, Barton M, Danser AHJ, de Leeuw PW, Dhaun N, et al. Endothelial factors in the pathogenesis and treatment of chronic kidney disease Part II: Role in disease conditions: a joint consensus statement from the European Society of Hypertension Working Group on Endothelin and Endothelial Factors and the Japanese Society of Hypertension. J Hypertens 2018;36(3):462-471 View Article
  29. Chamberlain AM, Redfield MM, Alonso A, Weston SA, Roger VL. Atrial fibrillation and mortality in heart failure: a community study. Circ Heart Fail 2011;4(6):740-746 View Article
  • Exploratory Research and Hypothesis in Medicine
  • pISSN 2993-5113
  • eISSN 2472-0712
Back to Top

Coronary Lesions in Patients with Atrial Fibrillation: A Retrospective Study

Yi-Wen Chen, Shu-Dong Xia
  • Reset Zoom
  • Download TIFF